234 related articles for article (PubMed ID: 11735085)
1. Magnesium reduces insulin-stimulated glucose uptake and serum lipid concentrations in type 1 diabetes.
Djurhuus MS; Klitgaard NA; Pedersen KK; Blaabjerg O; Altura BM; Altura BT; Henriksen JE
Metabolism; 2001 Dec; 50(12):1409-17. PubMed ID: 11735085
[TBL] [Abstract][Full Text] [Related]
2. Effect of oral magnesium supplementation on the lipid profile and blood glucose of patients with type 2 diabetes mellitus.
Lal J; Vasudev K; Kela AK; Jain SK
J Assoc Physicians India; 2003 Jan; 51():37-42. PubMed ID: 12693452
[TBL] [Abstract][Full Text] [Related]
3. Premeal insulin lispro plus bedtime NPH or twice-daily NPH in patients with type 2 diabetes: acute postprandial and chronic effects on glycemic control and cardiovascular risk factors.
Ceriello A; Del Prato S; Bue-Valleskey J; Beattie S; Gates J; de la Peña A; Malone J
J Diabetes Complications; 2007; 21(1):20-7. PubMed ID: 17189870
[TBL] [Abstract][Full Text] [Related]
4. Short-term effect of buformin, a biguanide, on insulin sensitivity, soluble fraction of tumor necrosis factor receptor and serum lipids in overweight patients with type 2 diabetes mellitus.
Ohara S; Komatsu R; Matsuyama T
Diabetes Res Clin Pract; 2004 Nov; 66(2):133-8. PubMed ID: 15533580
[TBL] [Abstract][Full Text] [Related]
5. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
Petersen KR
Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
[TBL] [Abstract][Full Text] [Related]
6. Effects of oral zinc and magnesium supplementation on serum thyroid hormone and lipid levels in experimentally induced diabetic rats.
Baydas B; Karagoz S; Meral I
Biol Trace Elem Res; 2002 Sep; 88(3):247-53. PubMed ID: 12350134
[TBL] [Abstract][Full Text] [Related]
7. Effect of oral magnesium sulfate administration on blood pressure and lipid profile in streptozocin diabetic rat.
Soltani N; Keshavarz M; Dehpour AR
Eur J Pharmacol; 2007 Apr; 560(2-3):201-5. PubMed ID: 17292879
[TBL] [Abstract][Full Text] [Related]
8. The impact of vitamin and/or mineral supplementation on lipid profiles in type 2 diabetes.
Farvid MS; Siassi F; Jalali M; Hosseini M; Saadat N
Diabetes Res Clin Pract; 2004 Jul; 65(1):21-8. PubMed ID: 15163474
[TBL] [Abstract][Full Text] [Related]
9. Insulin signalling in skeletal muscle of subjects with or without Type II-diabetes and first degree relatives of patients with the disease.
Meyer MM; Levin K; Grimmsmann T; Beck-Nielsen H; Klein HH
Diabetologia; 2002 Jun; 45(6):813-22. PubMed ID: 12107725
[TBL] [Abstract][Full Text] [Related]
10. Skeletal muscle magnesium content in identical twins, discordant for type 2 diabetes.
Djurhuus MS; Vaag A; Altura BM; Altura BT; Klitgaard NA
Diabetes Metab; 2002 Jun; 28(3):201-7. PubMed ID: 12149600
[TBL] [Abstract][Full Text] [Related]
11. Effects of a 3-day low-fat diet on metabolic control, insulin sensitivity, lipids and adipocyte hormones in Norwegian subjects with hypertriacylglycerolaemia and type 2 diabetes.
Mostad IL; Qvigstad E; Bjerve KS; Grill VE
Scand J Clin Lab Invest; 2004; 64(6):565-74. PubMed ID: 15370462
[TBL] [Abstract][Full Text] [Related]
12. Effects of oral magnesium supplementation on glycaemic control in Type 2 diabetes: a meta-analysis of randomized double-blind controlled trials.
Song Y; He K; Levitan EB; Manson JE; Liu S
Diabet Med; 2006 Oct; 23(10):1050-6. PubMed ID: 16978367
[TBL] [Abstract][Full Text] [Related]
13. Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study.
Egert S; Bosy-Westphal A; Seiberl J; Kürbitz C; Settler U; Plachta-Danielzik S; Wagner AE; Frank J; Schrezenmeir J; Rimbach G; Wolffram S; Müller MJ
Br J Nutr; 2009 Oct; 102(7):1065-74. PubMed ID: 19402938
[TBL] [Abstract][Full Text] [Related]
14. Serum magnesium levels in non-diabetic offspring of patients with Type 2 diabetes mellitus.
Maltezos E; Papazoglou D; Exiara T; Kambouromiti G; Antonoglou C
Diabetes Nutr Metab; 2004 Feb; 17(1):12-6. PubMed ID: 15163119
[TBL] [Abstract][Full Text] [Related]
15. Magnesium metabolism in type 2 diabetes mellitus, metabolic syndrome and insulin resistance.
Barbagallo M; Dominguez LJ
Arch Biochem Biophys; 2007 Feb; 458(1):40-7. PubMed ID: 16808892
[TBL] [Abstract][Full Text] [Related]
16. Supplementation of hydrogen-rich water improves lipid and glucose metabolism in patients with type 2 diabetes or impaired glucose tolerance.
Kajiyama S; Hasegawa G; Asano M; Hosoda H; Fukui M; Nakamura N; Kitawaki J; Imai S; Nakano K; Ohta M; Adachi T; Obayashi H; Yoshikawa T
Nutr Res; 2008 Mar; 28(3):137-43. PubMed ID: 19083400
[TBL] [Abstract][Full Text] [Related]
17. Statins and diabetes.
Carmena R; Betteridge DJ
Semin Vasc Med; 2004 Nov; 4(4):321-32. PubMed ID: 15861314
[TBL] [Abstract][Full Text] [Related]
18. Comparison of lipid profiles and lipoprotein a levels in patients with type 2 diabetes mellitus during oral hypoglycemic or insulin therapy.
Habib SS; Aslam M; Naveed AK; Razi MS
Saudi Med J; 2006 Feb; 27(2):174-80. PubMed ID: 16501671
[TBL] [Abstract][Full Text] [Related]
19. Magnesium status and association with diabetes in the Taiwanese elderly.
Wang JL; Shaw NS; Yeh HY; Kao MD
Asia Pac J Clin Nutr; 2005; 14(3):263-9. PubMed ID: 16169838
[TBL] [Abstract][Full Text] [Related]
20. Long-term consumption of a carbohydrate-restricted diet does not induce deleterious metabolic effects.
Grieb P; Kłapcińska B; Smol E; Pilis T; Pilis W; Sadowska-Krepa E; Sobczak A; Bartoszewicz Z; Nauman J; Stańczak K; Langfort J
Nutr Res; 2008 Dec; 28(12):825-33. PubMed ID: 19083495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
